173 related articles for article (PubMed ID: 12501241)
1. Three-dimensional structures of the mammalian multidrug resistance P-glycoprotein demonstrate major conformational changes in the transmembrane domains upon nucleotide binding.
Rosenberg MF; Kamis AB; Callaghan R; Higgins CF; Ford RC
J Biol Chem; 2003 Mar; 278(10):8294-9. PubMed ID: 12501241
[TBL] [Abstract][Full Text] [Related]
2. Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis.
Rosenberg MF; Callaghan R; Ford RC; Higgins CF
J Biol Chem; 1997 Apr; 272(16):10685-94. PubMed ID: 9099718
[TBL] [Abstract][Full Text] [Related]
3. Repacking of the transmembrane domains of P-glycoprotein during the transport ATPase cycle.
Rosenberg MF; Velarde G; Ford RC; Martin C; Berridge G; Kerr ID; Callaghan R; Schmidlin A; Wooding C; Linton KJ; Higgins CF
EMBO J; 2001 Oct; 20(20):5615-25. PubMed ID: 11598005
[TBL] [Abstract][Full Text] [Related]
4.
Futamata R; Ogasawara F; Ichikawa T; Kodan A; Kimura Y; Kioka N; Ueda K
J Biol Chem; 2020 Apr; 295(15):5002-5011. PubMed ID: 32111736
[TBL] [Abstract][Full Text] [Related]
5. The ATPase and ATP-binding functions of P-glycoprotein--modulation by interaction with defined phospholipids.
Romsicki Y; Sharom FJ
Eur J Biochem; 1998 Aug; 256(1):170-8. PubMed ID: 9746361
[TBL] [Abstract][Full Text] [Related]
6. Conformational changes of P-glycoprotein by nucleotide binding.
Wang G; Pincheira R; Zhang M; Zhang JT
Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):897-904. PubMed ID: 9396736
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional structure of P-glycoprotein: the transmembrane regions adopt an asymmetric configuration in the nucleotide-bound state.
Rosenberg MF; Callaghan R; Modok S; Higgins CF; Ford RC
J Biol Chem; 2005 Jan; 280(4):2857-62. PubMed ID: 15485807
[TBL] [Abstract][Full Text] [Related]
8. Cloning, overexpression, purification, and characterization of the carboxyl-terminal nucleotide binding domain of P-glycoprotein.
Sharma S; Rose DR
J Biol Chem; 1995 Jun; 270(23):14085-93. PubMed ID: 7775470
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide-induced structural changes in P-glycoprotein observed by electron microscopy.
Lee JY; Urbatsch IL; Senior AE; Wilkens S
J Biol Chem; 2008 Feb; 283(9):5769-79. PubMed ID: 18093977
[TBL] [Abstract][Full Text] [Related]
10. The structure of the multidrug resistance protein 1 (MRP1/ABCC1). crystallization and single-particle analysis.
Rosenberg MF; Mao Q; Holzenburg A; Ford RC; Deeley RG; Cole SP
J Biol Chem; 2001 May; 276(19):16076-82. PubMed ID: 11279022
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans.
Jin MS; Oldham ML; Zhang Q; Chen J
Nature; 2012 Oct; 490(7421):566-9. PubMed ID: 23000902
[TBL] [Abstract][Full Text] [Related]
12. Purification and crystallization of the cystic fibrosis transmembrane conductance regulator (CFTR).
Rosenberg MF; Kamis AB; Aleksandrov LA; Ford RC; Riordan JR
J Biol Chem; 2004 Sep; 279(37):39051-7. PubMed ID: 15247233
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for gating mechanisms of a eukaryotic P-glycoprotein homolog.
Kodan A; Yamaguchi T; Nakatsu T; Sakiyama K; Hipolito CJ; Fujioka A; Hirokane R; Ikeguchi K; Watanabe B; Hiratake J; Kimura Y; Suga H; Ueda K; Kato H
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4049-54. PubMed ID: 24591620
[TBL] [Abstract][Full Text] [Related]
14. Computational Insights into Allosteric Conformational Modulation of P-Glycoprotein by Substrate and Inhibitor Binding.
Xing J; Huang S; Heng Y; Mei H; Pan X
Molecules; 2020 Dec; 25(24):. PubMed ID: 33353070
[TBL] [Abstract][Full Text] [Related]
15. Drug binding in human P-glycoprotein causes conformational changes in both nucleotide-binding domains.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2003 Jan; 278(3):1575-8. PubMed ID: 12421806
[TBL] [Abstract][Full Text] [Related]
16. Data-driven homology modelling of P-glycoprotein in the ATP-bound state indicates flexibility of the transmembrane domains.
Stockner T; de Vries SJ; Bonvin AM; Ecker GF; Chiba P
FEBS J; 2009 Feb; 276(4):964-72. PubMed ID: 19215299
[TBL] [Abstract][Full Text] [Related]
17. The central cavity of ABCB1 undergoes alternating access during ATP hydrolysis.
van Wonderen JH; McMahon RM; O'Mara ML; McDevitt CA; Thomson AJ; Kerr ID; MacMillan F; Callaghan R
FEBS J; 2014 May; 281(9):2190-2201. PubMed ID: 24597976
[TBL] [Abstract][Full Text] [Related]
18. The vinblastine binding site adopts high- and low-affinity conformations during a transport cycle of P-glycoprotein.
Martin C; Higgins CF; Callaghan R
Biochemistry; 2001 Dec; 40(51):15733-42. PubMed ID: 11747450
[TBL] [Abstract][Full Text] [Related]
19. Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1).
Sharom FJ
Biochem Cell Biol; 2006 Dec; 84(6):979-92. PubMed ID: 17215884
[TBL] [Abstract][Full Text] [Related]
20. About a switch: how P-glycoprotein (ABCB1) harnesses the energy of ATP binding and hydrolysis to do mechanical work.
Sauna ZE; Ambudkar SV
Mol Cancer Ther; 2007 Jan; 6(1):13-23. PubMed ID: 17237262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
